HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Yamauchi, K. Articles by Katsuyama, T. Search for Related Content PubMed PubMed Citation Articles by Yamauchi, K. Articles by Katsuyama, T. Related Collections Lipids, Lipoproteins, and Cardiovascular Risk Factors Endocrinology and Metabolism Automation and Analytical Techniques

Apolipoprotein E in Cerebrospinal Fluid: Relation to Phenotype and Plasma Apolipoprotein E Concentrations

¹ Central Clinical Laboratories, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

² Department of Functional Polymer Science, Faculty of Textile Science and Technology, Shinshu University, 3-15-1 Tokita, Ueda 386-0018, Japan.

³ Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
^a Author for correspondence. Fax 81-263-34-5316; e-mail mtozuka{at}hsp.md.shinshu-u.ac.jp

Background: Apolipoprotein (apo) E may be related to the development of Alzheimer disease, but data on apoE in cerebrospinal fluid (CSF) are limited. The aim of the present study was to measure apoE in CSF and relate its concentrations to apoE phenotype and CSF lipids.

Methods: We adapted an assay for CSF apoE sensitivity using an ELISA. It allowed us to measure CSF apoE with sufficient reproducibility and precision.

Results: The within- and between-run CVs were <7%, and the detection limit was 0.025 mg/L. No cross-reaction was found for other apolipoproteins. No significant differences related to sex or apoE phenotype were observed in the CSF apoE concentration. The mean CSF apoE concentration was significantly higher in the 0–5 year group (n = 6; 18.47 ± 1.14 mg/L, mean ± SD) than in the >5 year group (n = 34; 8.82 ± 3.31 mg/L). The mean concentrations of total cholesterol (TC) and phospholipid (PL) in CSF were 2.68 ± 2.16 and 6.50 ± 2.84 mg/L (n = 52), respectively. Although no significant differences in TC or PL in the CSF were found with respect to sex or age, the concentrations in subjects with the apoE phenotype E4/E3 were significantly lower than in those with E3/E3 and E3/E2. The concentrations of apoE, TC, and PL in CSF did not correlate with those in plasma. The time-related fluctuations in CSF apoE were independent of those in total protein and IgG. CSF apoE was significantly correlated with TC and PL concentrations in the CSF, but not with the number of cells in the CSF.

Conclusions: These findings support the idea that apoE and lipids are unable to cross the blood-brain barrier and that their concentrations in CSF may reflect production in central nervous tissue.© 1999 American Association for Clinical Chemistry

The following articles in journals at HighWire Press have cited this article:

				M. M. M. Wilhelmus, I. Otte-Holler, J. Davis, W. E. Van Nostrand, R. M. W. de Waal, and M. M. Verbeek Apolipoprotein E Genotype Regulates Amyloid-{beta} Cytotoxicity J. Neurosci., April 6, 2005; 25(14): 3621 - 3627. [Abstract] [Full Text] [PDF]

				T. Suzuki, M. Tozuka, K. Yamauchi, M. Sugano, T. Nakabayashi, N. Okumura, H. Hidaka, T. Katsuyama, and K. Higuchi Predominant Apolipoprotein J Exists as Lipid-poor Mixtures in Cerebrospinal Fluid Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 369 - 376. [Abstract] [Full Text] [PDF]

				K. Yamauchi, M. Tozuka, H. Hidaka, T. Nakabayashi, M. Sugano, and T. Katsuyama Isoform-specific Effect of Apolipoprotein E on Endocytosis of {beta}-Amyloid in Cultures of Neuroblastoma Cells Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 65 - 74. [Abstract] [Full Text] [PDF]

				S. Koch, N. Donarski, K. Goetze, M. Kreckel, H.-J. Stuerenburg, C. Buhmann, and U. Beisiegel Characterization of four lipoprotein classes in human cerebrospinal fluid J. Lipid Res., July 1, 2001; 42(7): 1143 - 1151. [Abstract] [Full Text] [PDF]

				M. Schiefermeier, H. Kollegger, C. Madl, C. Schwarz, M. Holzer, J. Kofler, and F. Sterz Apolipoprotein E Polymorphism : Survival and Neurological Outcome After Cardiopulmonary Resuscitation Stroke, September 1, 2000; 31(9): 2068 - 2073. [Abstract] [Full Text] [PDF]

				N. Demeester, G. Castro, C. Desrumaux, C. De Geitere, J. C. Fruchart, P. Santens, E. Mulleners, S. Engelborghs, P. P. De Deyn, J. Vandekerckhove, et al. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease J. Lipid Res., June 1, 2000; 41(6): 963 - 974. [Abstract] [Full Text]

				K. Yamauchi, M. Tozuka, H. Hidaka, E. Hidaka, Y. Kondo, and T. Katsuyama Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E Clin. Chem., September 1, 1999; 45(9): 1431 - 1438. [Abstract] [Full Text] [PDF]